The march toward rational therapeutics in children
- 1 December 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (12) , 1119-1123
Abstract
Although children suffer from many of the same diseases as adults, the majority of drugs are not approved for pediatric use. This places children at risk, either that they will not be treated adequately because of the lack of approved agents or that their physician will be lacking the necessary labeling information to treat appropriately with a given agent. This paper details the slow progress over the last 25 years toward providing pediatric labeling and thus providing children with optimal protection and range of treatment options.Keywords
This publication has 4 references indexed in Scilit:
- Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric PopulationsPediatrics, 1995
- Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric PopulationsPediatrics, 1977
- Fatal Circulatory Collapse in Premature Infants Receiving ChloramphenicolNew England Journal of Medicine, 1959
- A DIFFERENCE IN MORTALITY RATE AND INCIDENCE OF KERNICTERUS AMONG PREMATURE INFANTS ALLOTTED TO TWO PROPHYLACTIC ANTIBACTERIAL REGIMENSPediatrics, 1956